-
Published 2/10/2026
Leyde S, Tilhou AS, Tsui JI. Treatment of Methamphetamine Use Disorder-Reply. JAMA. 2026 Feb 10; 335(6):551. PMID: 41525062.
-
Published 10/7/2025
Leyde S, Tilhou AS, Tsui JI. Methamphetamine Use Disorder. JAMA. 2025 Oct 07; 334(13):1192-1193. PMID: 40900575.
-
Published 7/3/2025
Tilhou AS, Assoumou SA, Samet JH. Aligning Efforts to Boost Medications for Opioid Use Disorder and Pre-Exposure Prophylaxis for HIV. J Gen Intern Med. 2026 Jan; 41(2):516-520. PMID: 40610667.
-
Published 4/22/2025
Tilhou AS, Grucza RA, Xu KY. Substance-induced mental disorders and discontinuation of medication for opioid use disorder. Drug Alcohol Depend. 2025 Jul 01; 272:112685. PMID: 40319789.
-
Published 2/28/2025
Tilhou AS, Gasman S, Wang J, Standish K, White LF, Cogan A, Devlin M, Larochelle M, Adams WG. Assessing inequities in buprenorphine treatment across the care cascade. Drug Alcohol Depend. 2025 May 01; 270:112636. PMID: 40043350.